AAAAAA

   
Results: 1-6 |
Results: 6

Authors: PICARD S TALUSSOT C SERUSCLAT A AMBROSIO N BERTHEZENE F
Citation: S. Picard et al., MINIMALLY OXIDIZED LDL AS ESTIMATED BY A NEW METHOD INCREASE IN PLASMA OF TYPE-2 DIABETIC-PATIENTS WITH ATHEROSCLEROSIS OR NEPHROPATHY, Diabetes & metabolism, 22(1), 1996, pp. 25-30

Authors: PILLOT T GOETHALS M VANLOO B TALUSSOT C BRASSEUR R VANDEKERCKHOVE J ROSSENEU M LINS L
Citation: T. Pillot et al., FUSOGENIC PROPERTIES OF THE C-TERMINAL DOMAIN OF THE ALZHEIMER BETA-AMYLOID PEPTIDE, The Journal of biological chemistry, 271(46), 1996, pp. 28757-28765

Authors: BENETOLLO C LAMBERT G TALUSSOT C VANLOO B VANCAUTEREN T ROUY D DUBOIS H BAERT J KALOPISSIS A DENEFLE P CHAMBAZ J BRASSEUR R ROSSENEU M
Citation: C. Benetollo et al., LIPID-BINDING PROPERTIES OF SYNTHETIC PEPTIDE-FRAGMENTS OF HUMAN APOLIPOPROTEIN A-II, European journal of biochemistry, 242(3), 1996, pp. 657-664

Authors: GUERIN M DOLPHIN PJ TALUSSOT C GARDETTE J BERTHEZENE F CHAPMAN MJ
Citation: M. Guerin et al., PRAVASTATIN MODULATES CHOLESTERYL ESTER TRANSFER FROM HDL TO APO-B-CONTAINING LIPOPROTEINS AND LIPOPROTEIN SUBSPECIES PROFILE IN FAMILIAL HYPERCHOLESTEROLEMIA, Arteriosclerosis, thrombosis, and vascular biology, 15(9), 1995, pp. 1359-1368

Authors: GINON I TALUSSOT C PONSIN G CIAVATTI M
Citation: I. Ginon et al., DECREASED CAPACITY TO INHIBIT PLATELET HYPERACTIVITY AND TO STABILIZEPROSTACYCLIN OF HIGH-DENSITY-LIPOPROTEINS IN EXPERIMENTAL DIABETES, Acta diabetologica, 32(3), 1995, pp. 170-175

Authors: TALUSSOT C PONSIN G
Citation: C. Talussot et G. Ponsin, THE TRANSFORMATION OF NASCENT DISC SHAPED HIGH-DENSITY-LIPOPROTEINS INTO MATURE SPHERICAL HIGH-DENSITY-LIPOPROTEINS - CONFORMATIONAL-ANALYSIS OF APOLIPOPROTEIN-A-I IN MODEL INTERMEDIATE PARTICLES, Journal of theoretical biology, 169(2), 1994, pp. 143-152
Risultati: 1-6 |